Tobacco News and Research RSS Feed - Tobacco News and Research

Texting could promote medication adherence among chronically ill patients

Texting could promote medication adherence among chronically ill patients

Text messages can double the odds of medication adherence in patients with chronic disease. That is the central finding of a new study published today in JAMA Internal Medicine. [More]
Researchers identify new targets that may help prevent and cure colon cancer

Researchers identify new targets that may help prevent and cure colon cancer

When the audio on your television set or smart phone is too loud, you simply turn down the volume. What if we could do the same for the signaling in our bodies that essentially causes normal cells to turn cancerous? New discoveries by researchers at the Stephenson Cancer Center at the University of Oklahoma may point to new ways to do just that. [More]
WHO calls on governments to rate movies that portray tobacco use

WHO calls on governments to rate movies that portray tobacco use

The World Health Organization is calling on governments to rate movies that portray tobacco use in a bid to prevent children and adolescents from starting to smoke cigarettes and use other forms of tobacco. [More]
Cherry-flavoured e-cigarette users may be exposed to potentially harmful chemical

Cherry-flavoured e-cigarette users may be exposed to potentially harmful chemical

An analysis of 145 different electronic-cigarette flavoring products reveals that many e-cigarette users may be exposed to a potentially harmful chemical. In a research letter published online today in the peer-reviewed journal Thorax, a research team led by Maciej Goniewicz, PhD, PharmD, of Roswell Park Cancer Institute reports that high levels of the respiratory irritant benzaldehyde were detected in the vapor from most of the flavored nicotine products they studied, with the highest concentrations in vapor from cherry-flavored products. [More]
Researchers developing new methods to better analyze effects of e-cig flavorings

Researchers developing new methods to better analyze effects of e-cig flavorings

Faculty and student researchers at Rochester Institute of Technology's National Technical Institute for the Deaf are developing methods to better analyze the effects of flavorings used in electronic cigarettes (e-cigs). [More]
Second-hand smoke exposure linked to larger waist, poorer cognition in children

Second-hand smoke exposure linked to larger waist, poorer cognition in children

Exposure to second-hand smoke is associated with a larger waist and poorer cognition in children, researchers say. [More]
Zepatier receives FDA approval for treatment of chronic HCV genotypes 1 and 4 infections

Zepatier receives FDA approval for treatment of chronic HCV genotypes 1 and 4 infections

The U.S. Food and Drug Administration today approved Zepatier (elbasvir and grazoprevir) with or without ribavirin for the treatment of chronic hepatitis C virus (HCV) genotypes 1 and 4 infections in adult patients. [More]
Halaven (eribulin mesylate) approved for treatment of liposarcoma

Halaven (eribulin mesylate) approved for treatment of liposarcoma

The U.S. Food and Drug Administration today approved Halaven (eribulin mesylate), a type of chemotherapy, for the treatment of liposarcoma (a specific type of soft tissue sarcoma) that cannot be removed by surgery (unresectable) or is advanced (metastatic). This treatment is approved for patients who received prior chemotherapy that contained an anthracycline drug. [More]
Indoor air quality in hospitality venues that allow smoking is worse than outdoor, study finds

Indoor air quality in hospitality venues that allow smoking is worse than outdoor, study finds

Research carried out in six cities with dangerous levels of air pollution indicates that air quality inside venues that allow smoking is even worse than outdoors. [More]
Vital Strategies launched to improve global health

Vital Strategies launched to improve global health

A new name in global health - Vital Strategies was launched today, with a mission of reducing disease and premature death and helping to deliver a world where every person has the protection of a strong public health system. [More]

Study identifies discrimination, alcohol and tobacco as major predictors of panic attacks in minority Americans

A new study has identified discrimination, alcohol and tobacco as significant predictors of minority Americans' experiencing panic attacks — fearful spells with psychological symptoms that last a few minutes and are often debilitating and disruptive. [More]
Cardiovascular considerations crucial for CML TKI patients

Cardiovascular considerations crucial for CML TKI patients

A review of BCR–ABL1 tyrosine kinase inhibitors highlights the need to consider cardiovascular adverse event risk profiles when prescribing for patients with chronic myeloid leukaemia. [More]
FDA issues draft guidance to address cybersecurity vulnerabilities in medical devices

FDA issues draft guidance to address cybersecurity vulnerabilities in medical devices

The U.S. Food and Drug Administration today issued a draft guidance outlining important steps medical device manufacturers should take to continually address cybersecurity risks to keep patients safe and better protect the public health. [More]
New report reveals striking variation in cancer burden within AANHPI population

New report reveals striking variation in cancer burden within AANHPI population

A new report describes cancer among Asian Americans, Native Hawaiians, and Pacific Islanders (AANHPIs), and reports striking variation in the cancer burden within this population, reflecting vast differences in exposure to cancer risk factors. [More]
Adult smokers who use e-cigarettes 28% less likely to quit smoking

Adult smokers who use e-cigarettes 28% less likely to quit smoking

Electronic cigarettes are widely promoted and used to help smokers quit traditional cigarettes, but a new analysis from UC San Francisco found that adult smokers who use e-cigarettes are actually 28 percent less likely to stop smoking cigarettes. [More]
Teens who rate e-cigarettes ads as effective more likely to try them in the future

Teens who rate e-cigarettes ads as effective more likely to try them in the future

Adolescents are more likely to say they will try electronic cigarettes if they perceive TV ads for these products as effective, according to a new study by RTI International researchers. [More]
Cancer mortality continues to drop in the U.S.

Cancer mortality continues to drop in the U.S.

Steady reductions in smoking combined with advances in cancer prevention, early detection, and treatment have resulted in a 23% drop in the cancer death rate since its peak in 1991. The drop translates to more than 1.7 million cancer deaths averted through 2012. [More]
Integra Omnigraft Dermal Regeneration Matrix approved to treat certain diabetic foot ulcers

Integra Omnigraft Dermal Regeneration Matrix approved to treat certain diabetic foot ulcers

The U.S. Food and Drug Administration today approved a new indication for the Integra Omnigraft Dermal Regeneration Matrix (Omnigraft) to treat certain diabetic foot ulcers. The matrix device, which is made of silicone, cow collagen, and shark cartilage, is placed over the ulcer and provides an environment for new skin and tissue to regenerate and heal the wound. [More]
ISHLT issues new list of criteria to determine patient eligibility for heart transplant

ISHLT issues new list of criteria to determine patient eligibility for heart transplant

To determine patient eligibility for heart transplant, the International Society for Heart Lung Transplantation maintains a list of criteria, first issued in 2006, that acts as a guideline for physicians. [More]
U.S. Marshals seize nearly 90,000 bottles of dietary supplements containing kratom

U.S. Marshals seize nearly 90,000 bottles of dietary supplements containing kratom

The U.S. Food and Drug Administration announced today that U.S. Marshals, at the agency's request, seized nearly 90,000 bottles of dietary supplements labeled as containing kratom. The product, manufactured for and held by Dordoniz Natural Products LLC, located in South Beloit, Illinois, is marketed under the brand name RelaKzpro and worth more than $400,000. [More]
Advertisement
Advertisement